|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0007559,
umls-concept:C0008976,
umls-concept:C0015967,
umls-concept:C0030705,
umls-concept:C0031955,
umls-concept:C0034656,
umls-concept:C0040341,
umls-concept:C0087111,
umls-concept:C1136254,
umls-concept:C1257890,
umls-concept:C1707455,
umls-concept:C1880496,
umls-concept:C2603343
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1994-5-12
|
|
pubmed:abstractText |
To compare piperacillin and tobramycin with ceftazidime alone for the empiric treatment of fever in the neutropenic patient without evidence of skin infections or anaerobic infections.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0003-4819
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
120
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
834-44
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8154643-Adult,
pubmed-meshheading:8154643-Bacteremia,
pubmed-meshheading:8154643-Ceftazidime,
pubmed-meshheading:8154643-Drug Therapy, Combination,
pubmed-meshheading:8154643-Female,
pubmed-meshheading:8154643-Fever,
pubmed-meshheading:8154643-Gram-Negative Bacterial Infections,
pubmed-meshheading:8154643-Humans,
pubmed-meshheading:8154643-Male,
pubmed-meshheading:8154643-Middle Aged,
pubmed-meshheading:8154643-Neoplasms,
pubmed-meshheading:8154643-Neutropenia,
pubmed-meshheading:8154643-Odds Ratio,
pubmed-meshheading:8154643-Piperacillin,
pubmed-meshheading:8154643-Superinfection,
pubmed-meshheading:8154643-Tobramycin,
pubmed-meshheading:8154643-Treatment Outcome
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
|
|
pubmed:affiliation |
Division of Hematology, University Hospital St. Radboud, Nijmegen, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
